[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer Clin, 2016, 66(1): 7~30.
[2] Graboyes EM, Townsend ME, Kallogjeri D, et al. Evaluation of quality metrics for surgically treated laryngeal squamous cell carcinoma[J]. JAMA Otolaryngol Head Neck Surg, 2016, 142(12):1154~1163.
[3] Lewerenz J, Hewett SJ, Huang Y, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities[J]. Antioxid Redox Signal, 2013,18(5): 522~555.
[4] Pallast S, Arai K, Wang X, et al. 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress[J].Neurochem, 2009, 111(3): 882~889.
[5] Zhang RR, Pointer KB, Kuo JS. Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target[J]. Neurosurgery, 2015, 77(6):N16~17.
[6] Robert SM, Buckingham SC, Campbell SL, et al. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma[J]. Sci Transl Med, 2015, 7(289): 289~286.
[7] Guo W, Zhao Y, Zhang Z, et al. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma[J]. Cancer Lett, 2011, 312(1):55~61.
[8] Shiozaki A, Iitaka D, Ichikawa D, et al. xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinoma[J].Journal of gastroenterology,2014,49(5):853~63.
[9] Dixon SJ, Patel DN, Welsch M, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis[J]. Elife, 2014, 3:e02523.
[10] 吴伟刚,田圆,刘琢冰,等.SLC7A11基因表达沉默的肝癌细胞株的构建及筛选[J].现代肿瘤医学,2015,23(2):149~152. |
2019, Vol. 25 
